Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
Unambiguous and sensitive methods based on gas chromatography-chemical ionization mass spectrometry have been developed to quantitate cyclophosphamide and two alkylating and cytotoxic metabolites, phosphoramide mustard and nornitrogen mustard. The levels of these materials have been determined in the plasma and urine of five patients receiving cyclophosphamide, 60 or 75 mg/kg i.v. Peak plasma levels of phosphoramide mustard of 50 to 100 nmoles/ml were found at 3 hr after cyclophosphamide administration. Variable levels of nornitrogen mustard were found in the plasma. This product may be arising in part from the decomposition of other metabolites during sample storage and preparation.
D000293:Adolescent; D001711:Biotransformation; D002849:Chromatography, Gas; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism* / Q000652:urine; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008297:Male; D013058:Mass Spectrometry; D008466:Mechlorethamine / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000097:blood / Q000652:urine; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000096:biosynthesis* / Q000097:blood / Q000652:urine
D009588:Nitrogen Mustard Compounds; D008466:Mechlorethamine; D003520:Cyclophosphamide; C004933:nornitrogen mustard